Feasibility study of Glucagon-like peptide-1 analogues for the optimization of Outcomes in obese patients undergoing AbLation for Atrial Fibrillation (GOAL-AF) protocol.
Autorzy:
Win KZ; Department of Cardiology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. Armstrong M; Department of Hepatology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. SteedsRP; Department of Cardiology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. Kalla M; Department of Cardiology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. .; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. .
Pokaż więcej
Źródło:
Pilot and feasibility studies [Pilot Feasibility Stud] 2024 Feb 21; Vol. 10 (1), pp. 36. Date of Electronic Publication: 2024 Feb 21.
Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis network.
Autorzy:
Choy CH; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. SteedsRP; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. Pinney J; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Baig S; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. Turvey-Haigh L; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Wahid Y; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Cox H; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Zaphiriou A; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Srinivasan V; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Wilson D; Department of Cardiology, Worcestershire Royal Hospital, Worcester, UK. Fryearson J; Department of Cardiology, Warwick Hospital, South Warwickshire University NHS Foundation Trust, Warwick, UK. Ahamed M; Department of Cardiology, Birmingham Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Lim S; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. Chue C; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. Pratt G; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. Fontana M; Centre for Amyloidosis, Division of Medicine (Royal Free Campus), University College London, London, UK. Gillmore JD; Centre for Amyloidosis, Division of Medicine (Royal Free Campus), University College London, London, UK. Moody WE; Midlands Amyloidosis Service, Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. Electronic address: .
The Role of Transthoracic Echocardiography for Assessment of Mortality in Patients with Carcinoid Heart Disease Undergoing Valve Replacement.
Autorzy:
Brooke A; Department of Cardiology, University Hospitals Birmingham (Queen Elizabeth) NHS Hospitals Foundation Trust, Birmingham B15 2TH, UK. Porter-Bent S; Department of Cardiology, University Hospitals Birmingham (Queen Elizabeth) NHS Hospitals Foundation Trust, Birmingham B15 2TH, UK.; Institute of Cardiovascular Sciences, University of Birmingham, University Hospitals Birmingham (Queen Elizabeth) NHS Hospitals Foundation Trust, Birmingham B15 2TH, UK. Hodson J; Institute of Translational Medicine, University Hospitals Birmingham (Queen Elizabeth) NHS Hospitals Foundation Trust, Birmingham B15 2TH, UK. Ahmad R; Department of Cardiology, University Hospitals Birmingham (Queen Elizabeth) NHS Hospitals Foundation Trust, Birmingham B15 2TH, UK. Oelofse T; Department of Cardiac Anaesthesia and Intensive Care, University Hospitals Birmingham (Queen Elizabeth) NHS Hospitals Foundation Trust, Birmingham B15 2TH, UK. Singh H; Department of Cardiac Anaesthesia and Intensive Care, University Hospitals Birmingham (Queen Elizabeth) NHS Hospitals Foundation Trust, Birmingham B15 2TH, UK. Shah T; Birmingham Neuroendocrine Tumour Centre, University Hospitals Birmingham (Queen Elizabeth) NHS Hospitals Foundation Trust, Birmingham B15 2TH, UK. Ashoub A; Department of Cardiothoracic Surgery, University Hospitals Birmingham (Queen Elizabeth) NHS Hospitals Foundation Trust, Birmingham B15 2TH, UK. Rooney S; Department of Cardiothoracic Surgery, University Hospitals Birmingham (Queen Elizabeth) NHS Hospitals Foundation Trust, Birmingham B15 2TH, UK. SteedsRP; Department of Cardiology, University Hospitals Birmingham (Queen Elizabeth) NHS Hospitals Foundation Trust, Birmingham B15 2TH, UK.; Institute of Cardiovascular Sciences, University of Birmingham, University Hospitals Birmingham (Queen Elizabeth) NHS Hospitals Foundation Trust, Birmingham B15 2TH, UK.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Mar 21; Vol. 15 (6). Date of Electronic Publication: 2023 Mar 21.
Increased cardiac involvement in Fabry disease using blood-corrected native T1 mapping.
Autorzy:
Nickander J; Department of Clinical Physiology, Karolinska University Hospital, and Karolinska Institutet, Stockholm, Sweden. . Cole B; Kolling Institute, Royal North Shore Hospital, and University of Sydney, Sydney, Australia. Nordin S; Institute of Cardiovascular Science, University College London, London, UK. Vijapurapu R; Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK. SteedsRP; Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK. Moon JC; Institute of Cardiovascular Science, University College London, London, UK. Kellman P; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA. Ugander M; Department of Clinical Physiology, Karolinska University Hospital, and Karolinska Institutet, Stockholm, Sweden.; Kolling Institute, Royal North Shore Hospital, and University of Sydney, Sydney, Australia.; Charles Perkins Center, Faculty of Medicine and Health, University of Sydney, Sydney, Australia. Kozor R; Kolling Institute, Royal North Shore Hospital, and University of Sydney, Sydney, Australia.; Royal North Shore Hospital, North Shore Private Hospital, Sydney, Australia.; Sydney Medical School, University of Sydney, Sydney, Australia.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Mar 17; Vol. 13 (1), pp. 4420. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
Left ventricular T1-mapping in diastole versus systole in patients with mitral regurgitation.
Autorzy:
Liu B; Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.; Department of Cardiology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK. Sharma H; Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. .; Department of Cardiology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK. . Su Khin K; Department of Cardiology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK. Wesolowski R; Institute of Translational Medicine, University Hospitals Birmingham, Birmingham, UK. Hothi SS; Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.; Royal Wolverhampton NHS Hospitals Trust, Wolverhampton Road, Wolverhampton, WV10 0QP, UK. Myerson SG; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. SteedsRP; Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK. rick.steeds@uhb.nhs.uk.; Department of Cardiology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, B15 2TH, UK. rick.steeds@uhb.nhs.uk.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Nov 21; Vol. 12 (1), pp. 20000. Date of Electronic Publication: 2022 Nov 21.
Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis.
Autorzy:
Chacko L; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Karia N; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Venneri L; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Bandera F; Heart Failure Unit, Cardiology University Department, IRCCS Policlinico San Donato, Milan, Italy.; Department for Biomedical Sciences for Health, University of Milano, Milan, Italy. Passo BD; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Buonamici L; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Lazari J; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Ioannou A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Porcari A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK.; Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy. Patel R; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Razvi Y; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Brown J; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Knight D; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Martinez-Naharro A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Whelan C; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Quarta CC; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Manisty C; Barts Heart Centre, The Cardiovascular Magnetic Resonance Imaging Unit, and the Inherited Cardiovascular Diseases Unit, St Bartholomew's Hospital, London, UK. Moon J; Barts Heart Centre, The Cardiovascular Magnetic Resonance Imaging Unit, and the Inherited Cardiovascular Diseases Unit, St Bartholomew's Hospital, London, UK. Rowczenio D; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Gilbertson JA; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Lachmann H; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Wechelakar A; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Petrie A; Eastman Dental Institute, University College London, London, UK. Moody WE; Department of Cardiology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK. SteedsRP; Department of Cardiology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Birmingham, UK. Potena L; Division of Cardiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Riefolo M; Division of Pathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Leone O; Division of Pathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Rapezzi C; Cardiologic Center, University of Ferrara, Ferrara, Italy.; Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy. Hawkins PN; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Gillmore JD; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK. Fontana M; National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Campus, London, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Sep; Vol. 24 (9), pp. 1700-1712. Date of Electronic Publication: 2022 Jul 27.
A Longitudinal Study of Mitral Regurgitation Detected after Acute Myocardial Infarction.
Autorzy:
Sharma H; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.; Department of Cardiology, University Hospitals Birmingham, Birmingham B15 2TH, UK. Yuan M; Department of Cardiology, University Hospitals Birmingham, Birmingham B15 2TH, UK. Shakeel I; Medical and Dental School, University of Birmingham, Birmingham B15 2TT, UK. Hodson J; Institute of Translational Medicine, University Hospitals Birmingham, Birmingham B15 2TH, UK.; Department of Health Informatics, University Hospitals Birmingham, Birmingham B15 2TH, UK. Radhakrishnan A; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.; Department of Cardiology, University Hospitals Birmingham, Birmingham B15 2TH, UK. Brown S; Medical and Dental School, University of Birmingham, Birmingham B15 2TT, UK. May J; Department of Cardiology, University Hospitals Birmingham, Birmingham B15 2TH, UK. O'Connor K; Department of Cardiology, University Hospitals Birmingham, Birmingham B15 2TH, UK. Zia N; Medical and Dental School, University of Birmingham, Birmingham B15 2TT, UK. Doshi SN; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.; Department of Cardiology, University Hospitals Birmingham, Birmingham B15 2TH, UK. Hothi SS; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.; Department of Cardiology, Royal Wolverhampton NHS Hospitals Trust, Wolverhampton WV10 0QP, UK. Townend JN; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.; Department of Cardiology, University Hospitals Birmingham, Birmingham B15 2TH, UK. Myerson SG; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, UK. Ludman PF; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.; Department of Cardiology, University Hospitals Birmingham, Birmingham B15 2TH, UK. SteedsRP; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.; Department of Cardiology, University Hospitals Birmingham, Birmingham B15 2TH, UK. Nadir MA; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.; Department of Cardiology, University Hospitals Birmingham, Birmingham B15 2TH, UK.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2022 Feb 13; Vol. 11 (4). Date of Electronic Publication: 2022 Feb 13.
Cardiac device implantation and device usage in Fabry and hypertrophic cardiomyopathy.
Autorzy:
Vijapurapu R; Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK.; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK.; Department of Endocrinology, Department of Inherited Metabolic Disorders, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, UK. Bradlow W; Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK. Leyva F; Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK.; Aston Medical Research Institute, Aston Medical School, Birmingham, UK. Moon JC; Department of Cardiology, Barts Heart Centre, London, UK. Zegard A; Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK. Lewis N; South Yorkshire Cardiothoracic Centre, Northern General Hospital, Sheffield, UK. Kotecha D; Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK.; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. Jovanovic A; Mark Holland Metabolic Unit, Salford Royal Hospital, Salford, UK. Hughes DA; Lysosomal Storage Disorder Unit, Royal Free Hospital, London, UK. Woolfson P; Department of Cardiology, Salford Royal Hospital, Salford, UK. SteedsRP; Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK.; Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK. Geberhiwot T; Department of Endocrinology, Department of Inherited Metabolic Disorders, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, UK. .; Institute of Metabolism and System Research, University of Birmingham, Birmingham, UK. .
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2022 Jan 06; Vol. 17 (1), pp. 6. Date of Electronic Publication: 2022 Jan 06.
Myocardial fibrosis in asymptomatic and symptomatic chronic severe primary mitral regurgitation and relationship to tissue characterisation and left ventricular function on cardiovascular magnetic resonance.
Autorzy:
Liu B; Department of Cardiology, University Hospital Birmingham, Birmingham, UK.; Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK. Neil DAH; Department of Cellular Pathology, University Hospital Birmingham, Birmingham, UK.; School of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. Premchand M; Department of Cardiology, University Hospital Birmingham, Birmingham, UK. Bhabra M; Department of Cardiothoracic Surgery, University Hospital Birmingham, Birmingham, UK. Patel R; Department of Cardiothoracic Surgery, University Hospital Coventry, Coventry, UK. Barker T; Department of Cardiothoracic Surgery, University Hospital Coventry, Coventry, UK. Nikolaidis N; Department of Cardiothoracic Surgery, New Cross Hospital, Wolverhampton, UK. Billing JS; Department of Cardiothoracic Surgery, New Cross Hospital, Wolverhampton, UK. Treibel TA; Institute for Cardiovascular Sciences, University College London, London, UK.; Department for Cardiac Imaging, Barts Heart Centre, St. Bartholomew's Hospital, London, UK. Moon JC; Institute for Cardiovascular Sciences, University College London, London, UK.; Department for Cardiac Imaging, Barts Heart Centre, St. Bartholomew's Hospital, London, UK. González A; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain.; CIBERCV, Instituto de Salud Carlos III, Madrid, Spain. Hodson J; Department of Statistics, Institute of Translational Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, UK. Edwards NC; Green Lane Cardiovascular Service, Department of Cardiology, Auckland City Hospital, Auckland, New Zealand. SteedsRP; Department of Cardiology, University Hospital Birmingham, Birmingham, UK. rick.steeds@uhb.nhs.uk.; Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK. rick.steeds@uhb.nhs.uk.
Prospective cardiovascular magnetic resonance imaging in adults with Alström syndrome: silent progression of diffuse interstitial fibrosis.
Autorzy:
Baig S; Department of Inherited Metabolic Disorders, Queen Elizabeth Hospital Birmingham, Birmingham, UK.; Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK. Dowd R; Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK. Edwards NC; Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK.; Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK. Hodson J; Institute of Translational Medicine, Queen Elizabeth Hospital, Birmingham, UK. Fabritz L; Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK.; Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK. Vijapurapu R; Department of Inherited Metabolic Disorders, Queen Elizabeth Hospital Birmingham, Birmingham, UK.; Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK. Liu B; Department of Inherited Metabolic Disorders, Queen Elizabeth Hospital Birmingham, Birmingham, UK.; Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK. Geberhiwot T; Department of Inherited Metabolic Disorders, Queen Elizabeth Hospital Birmingham, Birmingham, UK.; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK. SteedsRP; Institute of Cardiovascular Science, University of Birmingham, Birmingham, UK. Rick.Steeds@uhb.nhs.uk.; Department of Cardiology, Queen Elizabeth Hospital, Birmingham, UK. Rick.Steeds@uhb.nhs.uk.; Department of Cardiology, First Floor, Nuffield House, University Hospital Birmingham NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham, B15 2GW, UK. Rick.Steeds@uhb.nhs.uk.
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2020 Jun 05; Vol. 15 (1), pp. 139. Date of Electronic Publication: 2020 Jun 05.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
